• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物组分析揭示了适用于不同人群和技术的结直肠癌通用诊断生物标志物。

Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies.

作者信息

Zhang Huarong, Wu Junling, Ji Daihan, Liu Yijuan, Lu Shuting, Lin Zeman, Chen Ting, Ao Lu

机构信息

Key Laboratory of Ministry of Education for Gastrointestinal Cancer, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.

Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.

出版信息

Front Microbiol. 2022 Nov 3;13:1005201. doi: 10.3389/fmicb.2022.1005201. eCollection 2022.

DOI:10.3389/fmicb.2022.1005201
PMID:36406447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9668862/
Abstract

The gut microbial dysbiosis is a risk of colorectal cancer (CRC) and some bacteria have been reported as potential markers for CRC diagnosis. However, heterogeneity among studies with different populations and technologies lead to inconsistent results. Here, we investigated six metagenomic profiles of stool samples from healthy controls (HC), colorectal adenoma (CA) and CRC, and six and four genera were consistently altered between CRC and HC or CA across populations, respectively. In FengQ cohort, which composed with 61 HC, 47 CA, and 46 CRC samples, a random forest (RF) model composed of the six genera, denoted as signature-HC, distinguished CRC from HC with an area under the curve (AUC) of 0.84. Similarly, another RF model composed of the four universal genera, denoted as signature-CA, discriminated CRC from CA with an AUC of 0.73. These signatures were further validated in five metagenomic sequencing cohorts and six independent 16S rRNA gene sequencing cohorts. Interestingly, three genera overlapped in the two models (, and ) were with very low abundance in HC and CA, but sharply increased in CRC. A concise RF model on the three genera distinguished CRC from HC or CA with AUC of 0.87 and 0.67, respectively. Functional gene family analysis revealed that Kyoto Encyclopedia of Genes and Genomes Orthogroups categories which were significantly correlated with markers in signature-HC and signature-CA were mapped into pathways related to lipopolysaccharide and sulfur metabolism, which might be vital risk factors of CRC development. Conclusively, our study identified universal bacterial markers across populations and technologies as potential aids in non-invasive diagnosis of CRC.

摘要

肠道微生物群失调是结直肠癌(CRC)的一个风险因素,一些细菌已被报道为CRC诊断的潜在标志物。然而,不同人群和技术的研究之间的异质性导致结果不一致。在此,我们研究了来自健康对照(HC)、结直肠腺瘤(CA)和CRC的粪便样本的六个宏基因组图谱,并且在不同人群中,分别有六个和四个属在CRC与HC或CA之间持续发生改变。在由61例HC、47例CA和46例CRC样本组成的FengQ队列中,由这六个属组成的随机森林(RF)模型(记为signature-HC)区分CRC与HC的曲线下面积(AUC)为0.84。同样,另一个由四个普遍存在的属组成的RF模型(记为signature-CA)区分CRC与CA的AUC为0.73。这些标志物在五个宏基因组测序队列和六个独立的16S rRNA基因测序队列中得到了进一步验证。有趣的是,在两个模型中重叠的三个属(、和)在HC和CA中的丰度非常低,但在CRC中急剧增加。基于这三个属的一个简洁RF模型区分CRC与HC或CA的AUC分别为0.87和0.67。功能基因家族分析表明,与signature-HC和signature-CA中的标志物显著相关的京都基因与基因组百科全书直系同源组类别被映射到与脂多糖和硫代谢相关的途径中,这可能是CRC发生的重要风险因素。总之,我们的研究确定了跨人群和技术的普遍细菌标志物,作为CRC非侵入性诊断的潜在辅助手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/a4a9cded0f47/fmicb-13-1005201-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/f2ef8030dbd1/fmicb-13-1005201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/5edd33e31010/fmicb-13-1005201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/4d410a7fd8a8/fmicb-13-1005201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/805b9e7c73a4/fmicb-13-1005201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/6a5545851c4f/fmicb-13-1005201-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/da7c6066bcfb/fmicb-13-1005201-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/a4a9cded0f47/fmicb-13-1005201-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/f2ef8030dbd1/fmicb-13-1005201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/5edd33e31010/fmicb-13-1005201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/4d410a7fd8a8/fmicb-13-1005201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/805b9e7c73a4/fmicb-13-1005201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/6a5545851c4f/fmicb-13-1005201-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/da7c6066bcfb/fmicb-13-1005201-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e40/9668862/a4a9cded0f47/fmicb-13-1005201-g007.jpg

相似文献

1
Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies.微生物组分析揭示了适用于不同人群和技术的结直肠癌通用诊断生物标志物。
Front Microbiol. 2022 Nov 3;13:1005201. doi: 10.3389/fmicb.2022.1005201. eCollection 2022.
2
Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.多队列分析结直肠癌宏基因组在不同人群中鉴定出了改变的细菌和普遍的细菌标志物。
Microbiome. 2018 Apr 11;6(1):70. doi: 10.1186/s40168-018-0451-2.
3
Gut Microbial and Associated Metabolite Markers for Colorectal Cancer Diagnosis.用于结直肠癌诊断的肠道微生物及相关代谢物标志物
Microorganisms. 2023 Aug 8;11(8):2037. doi: 10.3390/microorganisms11082037.
4
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.粪便微生物组宏基因组分析作为结直肠癌靶向非侵入性生物标志物的工具。
Gut. 2017 Jan;66(1):70-78. doi: 10.1136/gutjnl-2015-309800. Epub 2015 Sep 25.
5
Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.基于宏基因组关联分析的结直肠癌粪便微生物标志物研究
Microbiol Spectr. 2022 Aug 31;10(4):e0001322. doi: 10.1128/spectrum.00013-22. Epub 2022 Jun 29.
6
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.肠病毒组的改变与结直肠癌及其生存预后相关。
Gastroenterology. 2018 Aug;155(2):529-541.e5. doi: 10.1053/j.gastro.2018.04.018. Epub 2018 Apr 22.
7
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.肠道微生物失调特征与结直肠癌变序列相关,并能提高结直肠病变的诊断效能。
J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22.
8
Fecal -- Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor.粪便——结直肠侧向发育型肿瘤无创诊断与预后的生物标志物。
Front Oncol. 2021 May 11;11:661048. doi: 10.3389/fonc.2021.661048. eCollection 2021.
9
Differential Mucosal Microbiome Profiles across Stages of Human Colorectal Cancer.人类结直肠癌各阶段的黏膜微生物群差异图谱
Life (Basel). 2021 Aug 13;11(8):831. doi: 10.3390/life11080831.
10
Features of combined gut bacteria and fungi from a Chinese cohort of colorectal cancer, colorectal adenoma, and post-operative patients.中国结直肠癌、结直肠腺瘤及术后患者队列中肠道细菌和真菌组合的特征
Front Microbiol. 2023 Aug 8;14:1236583. doi: 10.3389/fmicb.2023.1236583. eCollection 2023.

引用本文的文献

1
Metagenomic Signatures of Colorectal Cancer in the Jordanian Population: A Regional Case-Control Analysis Using 16S rRNA Profiling.约旦人群中结直肠癌的宏基因组特征:一项使用16S rRNA基因分型的区域病例对照分析。
Microorganisms. 2025 Aug 21;13(8):1963. doi: 10.3390/microorganisms13081963.
2
Gut Mucosal Microbiome of Patients With Low-Grade Adenomatous Bowel Polyps.低级别腺瘤性肠息肉患者的肠道黏膜微生物群
Gastro Hep Adv. 2025 Apr 28;4(8):100687. doi: 10.1016/j.gastha.2025.100687. eCollection 2025.
3
Differences in diversity and composition of mucosa-associated colonic microbiota in colorectal cancer and non-colorectal cancer in Indonesia.

本文引用的文献

1
Population structure discovery in meta-analyzed microbial communities and inflammatory bowel disease using MMUPHin.使用 MMUPHin 发现元分析微生物群落和炎症性肠病中的种群结构。
Genome Biol. 2022 Oct 3;23(1):208. doi: 10.1186/s13059-022-02753-4.
2
Activation of p38 mitogen-activated protein kinase pathway by lipopolysaccharide aggravates postoperative ileus in colorectal cancer patients.脂多糖通过激活 p38 丝裂原活化蛋白激酶通路加重结直肠癌患者术后肠梗阻。
J Gastroenterol Hepatol. 2022 Mar;37(3):518-530. doi: 10.1111/jgh.15760. Epub 2022 Jan 22.
3
Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
印度尼西亚结直肠癌与非结直肠癌患者中结肠黏膜相关微生物群的多样性和组成差异。
World J Gastroenterol. 2025 Feb 21;31(7):100051. doi: 10.3748/wjg.v31.i7.100051.
4
Detection of colorectal-cancer-associated bacterial taxa in fecal samples using next-generation sequencing and 19 newly established qPCR assays.使用下一代测序技术和19种新建立的定量聚合酶链反应检测粪便样本中与结直肠癌相关的细菌类群。
Mol Oncol. 2025 Feb;19(2):412-429. doi: 10.1002/1878-0261.13700. Epub 2024 Jul 6.
5
Quantitative and dynamic profiling of human gut core microbiota by real-time PCR.采用实时 PCR 技术对人体肠道核心微生物群进行定量和动态分析。
Appl Microbiol Biotechnol. 2024 Jun 26;108(1):396. doi: 10.1007/s00253-024-13204-4.
6
GDmicro: classifying host disease status with GCN and deep adaptation network based on the human gut microbiome data.GDmicro:基于人类肠道微生物组数据,使用 GCN 和深度自适应网络对宿主疾病状态进行分类。
Bioinformatics. 2023 Dec 1;39(12). doi: 10.1093/bioinformatics/btad747.
7
Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors.肠道微生物在免疫检查点抑制剂疗效和毒性中的潜在作用。
Front Pharmacol. 2023 Jun 21;14:1170591. doi: 10.3389/fphar.2023.1170591. eCollection 2023.
粪便宏基因组和血清代谢组的综合分析揭示了肠道微生物组相关代谢物在结直肠癌和腺瘤检测中的作用。
Gut. 2022 Jul;71(7):1315-1325. doi: 10.1136/gutjnl-2020-323476. Epub 2021 Aug 30.
4
Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.肠道细菌和病毒在结直肠癌中的改变、相互作用和诊断潜力。
Front Cell Infect Microbiol. 2021 Jul 6;11:657867. doi: 10.3389/fcimb.2021.657867. eCollection 2021.
5
Fecal -- Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor.粪便——结直肠侧向发育型肿瘤无创诊断与预后的生物标志物。
Front Oncol. 2021 May 11;11:661048. doi: 10.3389/fonc.2021.661048. eCollection 2021.
6
Identification of microbial markers across populations in early detection of colorectal cancer.跨人群识别微生物标志物用于结直肠癌的早期检测。
Nat Commun. 2021 May 24;12(1):3063. doi: 10.1038/s41467-021-23265-y.
7
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.脂多糖通过核因子-κB/蜗牛/己糖激酶3信号轴加速糖酵解,从而促进结直肠癌转移。
Cancer Metab. 2021 May 12;9(1):23. doi: 10.1186/s40170-021-00260-x.
8
Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.人类口腔微生物组失调作为一种新型非侵入性生物标志物在结直肠癌检测中的应用。
Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020.
9
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.微小帕毛单胞菌作为结直肠癌的一种潜在无侵犯性粪便生物标志物。
Sci Rep. 2020 Sep 17;10(1):15250. doi: 10.1038/s41598-020-72132-1.
10
A novel faecal marker for the non-invasive diagnosis of colorectal adenoma and cancer.一种用于结直肠腺瘤和癌症非侵入性诊断的新型粪便标志物。
Gut. 2020 Jul;69(7):1248-1257. doi: 10.1136/gutjnl-2019-318532. Epub 2019 Nov 27.